Cargando…
Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects
Lung cancer, the second most commonly diagnosed cancer, is the major cause of fatalities worldwide for both men and women, with an estimated 2.2 million new incidences and 1.8 million deaths, according to GLOBOCAN 2020. Although various risk factors for lung cancer pathogenesis have been reported, c...
Autores principales: | Gangwar, Shailendra Kumar, Kumar, Aviral, Yap, Kenneth Chun-Hong, Jose, Sandra, Parama, Dey, Sethi, Gautam, Kumar, Alan Prem, Kunnumakkara, Ajaikumar B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9145966/ https://www.ncbi.nlm.nih.gov/pubmed/35631448 http://dx.doi.org/10.3390/ph15050624 |
Ejemplares similares
-
The promising potential of piperlongumine as an emerging therapeutics for cancer
por: Parama, Dey, et al.
Publicado: (2021) -
Demystifying the Functional Role of Nuclear Receptors in Esophageal Cancer
por: Jayaprakash, Sujitha, et al.
Publicado: (2022) -
Emerging roles of cardamonin, a multitargeted nutraceutical in the prevention and treatment of chronic diseases
por: Daimary, Uzini Devi, et al.
Publicado: (2020) -
Targeting Autophagy Using Long Non-Coding RNAs (LncRNAs): New Landscapes in the Arena of Cancer Therapeutics
por: Kumar, Aviral, et al.
Publicado: (2023) -
Reiterating the Emergence of Noncoding RNAs as Regulators of the Critical Hallmarks of Gall Bladder Cancer
por: Rana, Varsha, et al.
Publicado: (2021)